Advertisement
Screener

INTELLIGENT BIO SOLUTIONS INC. (INBS) Business Acquisition, Pro Forma Earnings Per Share, Diluted

1.6 / 5 stars · 14/43 Roast Me

INTELLIGENT BIO SOLUTIONS INC. Business Acquisition, Pro Forma Earnings Per Share, Diluted

INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of -$127.00 per share for the 12-month period ending 2023-06-30, per its 10-K filed 2024-09-18.

Discontinued › Income Statement › Earnings Per Share

us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2024-09-18

  • INTELLIGENT BIO SOLUTIONS INC. business acquisition, pro forma earnings per share, diluted for fiscal 2023 was -$127.00.
Period endBusiness Acquisition, Pro Forma Earnings Per Share, Diluted 6 monthBusiness Acquisition, Pro Forma Earnings Per Share, Diluted 9 monthBusiness Acquisition, Pro Forma Earnings Per Share, Diluted 12 month
2023-06-30-$127.00
10-K · filed 2024-09-18
2023-03-31-$104.04
10-Q · filed 2024-05-08
2022-12-31-$23.65
10-Q · filed 2024-02-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
AETHLON MEDICAL INC (AEMD)United States$0.005B
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26